Results 201 to 210 of about 12,338 (219)

Bortezomib

Reactions Weekly, 2017
openaire   +1 more source

A Targeted and pH-Responsive Bortezomib Nanomedicine in the Treatment of Metastatic Bone Tumors

ACS Applied Materials & Interfaces, 2018
Xiaopan Cai, Changping Wang, Jianru Xiao   +2 more
exaly  

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Blood, 2010
Paul G Richardson, Sagar Lonial, Andrzej J Jakubowiak   +2 more
exaly  

Subcutaneous Bortezomib

Drugs, 2013
Sheridan M Hoy, Hoy Sheridan M
exaly  

Intracellular NAD+ depletion enhances bortezomib-induced anti-myeloma activity

Blood, 2013
Antonia Cagnetta, Michele Cea, TERESA Calimeri   +2 more
exaly  

Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein

Blood, 2008
Yehuda G Assaraf, Jacqueline Cloos, Celia R Berkers   +2 more
exaly  

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Blood, 2013
Ulf-Henrik Mellqvist, Peter Gimsing, Edward Laane   +2 more
exaly  

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

Oncogene, 2010
Kuen-Feng Chen, P-J Chen, A-L Cheng
exaly  

Efficacy of Therapy with Bortezomib in Solid Tumors: A Review based on 32 Clinical Trials

Future Oncology, 2014
Zebo Huang, Yinxia Wu
exaly  

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

British Journal of Haematology, 2004
D Irwin, Raymond Alexanian, M Alsina
exaly